-
-
-
-
-
-
-
Agenus presents biomarker data for cancer immunotherapy combination
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Agenus Inc. (AGEN)
-
-
-
-
-
-
-
Agenus (AGEN) Trades Higher in Sympathy with MiNK Therapeutics (INKT)
-
-
-
-
-
-
-
Agenus (AGEN) Misses Q1 EPS by 103c
-
-
-
-
-
-
-
Agenus (AGEN) Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
-
-
-
-
-
-
-
Agenus (AGEN) Misses Q2 EPS by 64c
-
-
-
-
-
-
-
Increasing unusual call option volume: VIRT AUR AGEN ITB APTV KOPN LPSN
-
428,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

